Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← All Wire coverage

Situationoutlier

Capricor soars on potential FDA review extension, filing amendments

9 reports · 6 domains · 3× the usual spread · 14 August 2026 → 25 August 2026

Far more widely carried than a normal story of its kind

Reports

9

Domains carrying it

6

First reported

14 August 2026

Latest report

25 August 2026

◆ Sectors

Biotech

◆ Where

United States

◆ Timeline

  1. 14 August 2026Capricor soars on potential FDA review extension, filing amendmentsbiospace.com
  2. 24 August 2026FDA delays Capricor's deramiocel PDUFA date to review new dataendpoints.news
  3. 25 August 2026FDA decision on DMD cell therapy pushed to Novembermusculardystrophynews.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

◆ Share

ShareXLinkedInEmail

◆ Wire has not analysed this situation yet

Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.

◆ Evidence

9 reports · 6 domains